Pulmonary arterial hypertension associated with hereditary hemorrhagic telangiectasia successfully treated with sildenafil

Int J Cardiol. 2016 Jul 1:214:275-6. doi: 10.1016/j.ijcard.2016.03.211. Epub 2016 Mar 31.
No abstract available

Keywords: ACVRL1 gene mutation; Hereditary hemorrhagic telangiectasia; Pulmonary arterial hypertension; Sildenafil.

Publication types

  • Case Reports

MeSH terms

  • Activin Receptors, Type II / genetics
  • Female
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Hypertension, Pulmonary / genetics
  • Middle Aged
  • Mutation, Missense
  • Pedigree
  • Pulmonary Arterial Hypertension
  • Sildenafil Citrate / administration & dosage*
  • Telangiectasis / congenital*
  • Telangiectasis / drug therapy
  • Telangiectasis / genetics
  • Treatment Outcome
  • Vasodilator Agents / administration & dosage

Substances

  • Vasodilator Agents
  • Sildenafil Citrate
  • ACVRL1 protein, human
  • Activin Receptors, Type II

Supplementary concepts

  • Pulmonary Arterial Hypertension, Hereditary Hemorrhagic Telangiectasia-Related